EU Commission outlines plans for accessible & affordable healthcare innovation
This article was originally published in Scrip
Executive Summary
Antonio Tajani, the European Commission's vice president responsible for industry and entrepreneurship, has called on member states to work to provide affordable access to medicines, especially orphan drugs and biosimilars, while still providing the pharma industry with appropriate incentives to innovate.